4//SEC Filing
STEINMETZ MICHAEL 4
Accession 0001209191-12-034491
CIK 0001339455other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 2:31 PM ET
Size
14.3 KB
Accession
0001209191-12-034491
Insider Transaction Report
Form 4
EVNIN LUKE
10% Owner
Transactions
- Sale
Common Stock
2012-06-15$0.29/sh−1,450$420→ 3,781,735 total(indirect: See Footnote)
GALAKATOS NICHOLAS
10% Owner
Transactions
- Sale
Common Stock
2012-06-15$0.29/sh−1,450$420→ 3,781,735 total(indirect: See Footnote)
SIMON NICHOLAS J III
10% Owner
Transactions
- Sale
Common Stock
2012-06-15$0.29/sh−1,450$420→ 3,781,735 total(indirect: See Footnote)
STEINMETZ MICHAEL
10% Owner
Transactions
- Sale
Common Stock
2012-06-15$0.29/sh−1,450$420→ 3,781,735 total(indirect: See Footnote)
WHEELER KURT
Director
Transactions
- Sale
Common Stock
2012-06-15$0.29/sh−1,450$420→ 3,781,735 total(indirect: See Footnote)
GADICKE ANSBERT
10% Owner
Transactions
- Sale
Common Stock
2012-06-15$0.29/sh−1,450$420→ 3,781,735 total(indirect: See Footnote)
HENNER DENNIS
10% Owner
Transactions
- Sale
Common Stock
2012-06-15$0.29/sh−1,450$420→ 3,781,735 total(indirect: See Footnote)
Footnotes (2)
- [F1]The shares were sold as follows: 1,209 by MPM BioVentures III-QP, L.P. ("BV III QP"), 81 by MPM BioVentures III, L.P. ("BV III"), 21 by MPM Asset Management Investors 2005 BVIII LLC ("AM 2005"), 37 by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel") and 102 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"). MPM BioVentures III GP, L.P. ("MPM III GP") and MPM BioVentures III LLC ("MPM III LLC") are the direct and indirect general partners of BV III QP, BV III, BV Parallel and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz and Kurt Wheeler are the Series A members of MPM III LLC and the managers of AM 2005.
- [F2]The shares are held as follows: 3,152,321 by BV III QP, 211,966 by BV III, 55,842 by AM 2005, 95,222 by BV Parallel and 266,384 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001166285
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 2:31 PM ET
- Size
- 14.3 KB